thromboxanes has been researched along with Hyperlipoproteinemia Type III in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schrör, K | 1 |
1 review(s) available for thromboxanes and Hyperlipoproteinemia Type III
| Article | Year |
|---|---|
Platelet reactivity and arachidonic acid metabolism in type II hyperlipoproteinaemia and its modification by cholesterol-lowering agents.
Topics: Anticholesteremic Agents; Arachidonic Acid; Arachidonic Acids; Blood Platelets; Cholesterol; Epoprostenol; Humans; Hyperlipoproteinemia Type III; Lipoproteins; Prostaglandin D2; Thromboxanes | 1990 |